News

Infectious Disease Advisor4h
FDA Drug Approval Decisions Expected in May 2025
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Medscape4h
FDA Authorizes First Prescription Digital Therapeutic for Migraine
The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...
The American Journal of Managed Care5h
5 Notable FDA Approvals From March Highlight Advancements Across Therapeutic Areas
From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.
Cancer Therapy Advisor4d
FDA Roundup: Oncology Drug Approvals in 2025
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...
Novartis, FDA Battle Over Generic Drug Labeling in DC Circuit
A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...